Literature DB >> 35952348

Endothelin-1 receptor blockade does not alter the sympathetic and hemodynamic response to acute intermittent hypoxia in men.

Jacqueline K Limberg1,2,3, Sarah E Baker1, Elizabeth P Ott2, Dain W Jacob2, Zachariah M Scruggs1, Jennifer L Harper2, Camila M Manrique-Acevedo4,5,3.   

Abstract

Repeat exposures to low oxygen (intermittent hypoxia, IH), like that observed in sleep apnea, elicit increases in muscle sympathetic nerve activity (MSNA) and blood pressure (BP) in men. Endothelin (ET) receptor antagonists can attenuate the sympathetic and BP response to IH in rodents; whether these data translate to humans are unclear. We hypothesized that ET-receptor antagonism would ameliorate any rise in MSNA and BP following acute IH in humans. Twelve healthy men (31 ± 1 yr) completed two visits (control, bosentan) separated by at least 1 wk. MSNA, BP, and baroreflex sensitivity (modified Oxford) were assessed during normoxic rest before and following 30 min of IH. The midpoint (T50) for each individual's baroreflex curve was calculated. Acute IH increased plasma ET-1 (P < 0.01), MSNA burst frequency (P = 0.03), and mean BP (P < 0.01). There was no effect of IH on baroreflex sensitivity (P = 0.46), although an increase in T50 was observed (P < 0.01). MSNA burst frequency was higher (P = 0.04) and mean BP (P < 0.01) was lower following bosentan treatment compared with control. There was no effect of bosentan on baroreflex sensitivity (P = 0.53), although a lower T50 was observed on the bosentan visit (P < 0.01). There was no effect of bosentan on increases in MSNA (P = 0.81) or mean BP (P = 0.12) following acute IH. Acute IH results in an increase in ET-1, MSNA, and BP in healthy young men. The effect of IH on MSNA and BP is not attenuated following ET-receptor inhibition. Present data suggest that acute IH does not increase MSNA or BP through activation of ET-receptors in healthy young men.NEW & NOTEWORTHY Repeat exposures to low oxygen (intermittent hypoxia, IH) elicit increases in muscle sympathetic nerve activity (MSNA) and blood pressure (BP) in men. Endothelin (ET) receptor antagonists can attenuate the sympathetic and BP response to IH in rodents; whether these data translate to humans were unclear. We show acute IH results in an increase in ET-1, MSNA, and BP in healthy young men; however, the effect of IH on MSNA and BP does not occur through activation of ET-receptors in healthy young men.

Entities:  

Keywords:  baroreflex sensitivity; blood pressure; endothelin-1; hypoxia; muscle sympathetic nerve activity

Mesh:

Substances:

Year:  2022        PMID: 35952348      PMCID: PMC9560055          DOI: 10.1152/japplphysiol.00837.2021

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  55 in total

1.  Obstructive sleep apnea: Plasma endothelin-1 precursor but not endothelin-1 levels are elevated and decline with nasal continuous positive airway pressure.

Authors:  Wolfgang Jordan; Alexander Reinbacher; Stefan Cohrs; Rolf W Grunewald; Geert Mayer; Eckart Rüther; Andrea Rodenbeck
Journal:  Peptides       Date:  2005-03-24       Impact factor: 3.750

2.  Intermittent hypoxia and arterial blood pressure control in humans: role of the peripheral vasculature and carotid baroreflex.

Authors:  Joshua C Tremblay; Lindsey M Boulet; Michael M Tymko; Glen E Foster
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-07-08       Impact factor: 4.733

3.  14 nights of intermittent hypoxia elevate daytime blood pressure and sympathetic activity in healthy humans.

Authors:  R Tamisier; J L Pépin; J Rémy; J P Baguet; J A Taylor; J W Weiss; P Lévy
Journal:  Eur Respir J       Date:  2010-06-04       Impact factor: 16.671

Review 4.  Clinical pharmacokinetics and drug-drug interactions of endothelin receptor antagonists in pulmonary arterial hypertension.

Authors:  Jürgen Venitz; Julia Zack; Hunter Gillies; Martine Allard; Jean Regnault; Christopher Dufton
Journal:  J Clin Pharmacol       Date:  2011-12-28       Impact factor: 3.126

5.  Acute intermittent hypercapnic hypoxia and sympathetic neurovascular transduction in men.

Authors:  Troy J R Stuckless; Tyler D Vermeulen; Courtney V Brown; Lindsey M Boulet; Brooke M Shafer; Denis J Wakeham; Craig D Steinback; Najib T Ayas; John S Floras; Glen E Foster
Journal:  J Physiol       Date:  2020-01-19       Impact factor: 5.182

6.  Endothelin-1 as a novel target for the prevention of metabolic dysfunction with intermittent hypoxia in male participants.

Authors:  Jacqueline K Limberg; Sarah E Baker; Humphrey G Petersen-Jones; Winston Guo; An Huang; Michael D Jensen; Prachi Singh
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2022-07-11       Impact factor: 3.210

7.  Pharmacokinetics and pharmacodynamics of the endothelin-receptor antagonist bosentan in healthy human subjects.

Authors:  C Weber; R Schmitt; H Birnboeck; G Hopfgartner; S P van Marle; P A Peeters; J H Jonkman; C R Jones
Journal:  Clin Pharmacol Ther       Date:  1996-08       Impact factor: 6.875

8.  Does endothelin play a role in chemoreception during acute hypoxia in normal men?

Authors:  Marko Gujic; Anne Houssière; Olivier Xhaët; Jean-François Argacha; Nathalie Denewet; André Noseda; Pascale Jespers; Christian Melot; Robert Naeije; Philippe van de Borne
Journal:  Chest       Date:  2007-05       Impact factor: 9.410

9.  Sympathetic neural recruitment strategies following acute intermittent hypoxia in humans.

Authors:  Elizabeth P Ott; Dain W Jacob; Sarah E Baker; Walter W Holbein; Zachariah M Scruggs; J Kevin Shoemaker; Jacqueline K Limberg
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-04-08       Impact factor: 3.619

10.  Accuracy of invasive arterial pressure monitoring in cardiovascular patients: an observational study.

Authors:  Stefano Romagnoli; Zaccaria Ricci; Diego Quattrone; Lorenzo Tofani; Omar Tujjar; Gianluca Villa; Salvatore M Romano; A Raffaele De Gaudio
Journal:  Crit Care       Date:  2014-11-30       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.